Precision Medicine Market: How Is Liquid Biopsy Transforming Cancer Monitoring and Early Detection?
Liquid biopsy in precision medicine — the non-invasive analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes from blood samples for cancer detection, monitoring, and minimal residual disease (MRD) assessment representing the fastest-growing diagnostic modality — creates the most patient-friendly market segment, with the Precision Medicine Market...
0 Комментарии 0 Поделились 10 Просмотры 0 предпросмотр